M. Professeur Jacques MOREL
27ans d'exercice (thèse 1999)
✨ Profil synthétique
IA · 09/05/2026Le Professeur Jacques MOREL est un rhumatologue à Montpellier avec une expertise reconnue dans le domaine de la recherche sur les maladies auto-immunes et inflammatoires. Ses travaux de recherche portent principalement sur le rhumatisme psoriasique, la maladie de Sjögren, les biothérapies et les corticothérapies. Avec un h-index de 59 et plus de 618 publications, il est un auteur prolifique dans son domaine.
Expertises présumées
- Rhumatisme psoriasique
- Maladie de Sjögren
- Biothérapies non-anti-TNF
- Thérapies anti-TNF
- Spondyloarthrite
- Lupus érythémateux systémique
- Corticothérapie
- csDMARDs
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Etude du rôle de l'interleukine-18 dans l'inflammation de la synoviale rhumatoide
2003Study of Il-18 implication in RA synovitis
Biologie ostéo-articulaire, biomécanique et biomatériaux🎓 Paris 7Direction : Bernard Combe
Etude de la régulation des gènes HLA-DM : application à la polyarthrite rhumatoi͏̈de
1999Médecine🎓 Montpellier 1Direction : Bernard Combe
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
59
h articles cités ≥ h fois chacun. Un h de 59 = 59 publications avec 59+ citations.
Citations
11 439
Publications
618
i10-index
173
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×215
- Systemic Lupus Erythematosus Research ×107
- Salivary Gland Disorders and Functions ×89
- Spondyloarthritis Studies and Treatments ×87
- Autoimmune and Inflammatory Disorders Research ×42
Affiliations FR : Centre National de la Recherche Scientifique · Inserm · Université de Montpellier
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure
2025ArticleInternational Journal of Infectious Diseases
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025ArticleThe Lancet Rheumatology
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
2025ArticleRMD Open
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025ArticleACR Open Rheumatology
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: data from the French national registry REGATE
2025ArticleJoint Bone Spine
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
2025ArticleArthritis & rheumatology
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial
2025ArticleAnnals of the Rheumatic Diseases
Phenotypes and prognosis of systemic sclerosis: a cluster analysis
2025ArticleRespiratory Medicine and Research
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation des cabinets
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET PRIVE DU DR JACQUES MOREL
HOPITAL LAPEYRONIE, IMMUNO-RHUMATOLOGIE — 371 AVENUE DU DOYEN GASTON GIRAUD, 34295 Montpellier
Libéral© OpenStreetMap · Photos Wikimedia Commons (CC)HOPITAL LAPEYRONIE CHU MONTPELLIER
371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier
© OpenStreetMap · Photos Wikimedia Commons (CC)
.jpg)
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (1)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Découvrez le classement des meilleurs médecins spécialistes d'Occitanie - L'Opinion Indépendante
📰 L'Opinion Indépendante · 27/05/2023
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNYlR5UjBneERIak80N0xBS3ZEV3RhUlkwNkxxUFJVRUtOa2pYOHFIaFU3aG4wS0hCWjE1N3RJdHZ6Y0k3OXZ0TXVfNEU0QXFlZ3h0endiR1oxOC01NElndEM3aGhOcFZtTUN1Rkk3Zk5CQkpRNzZLaU9mbENaZlhoZE1WMHY5bUltSnMwT2xRZ2twQ3NPZ3pTdFdn0gGfAUFVX3lxTFB3VktLVFFlRF9OSjFkUHVvRHJOTm
Top publications · les plus citées
- 12022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Annals of the rheumatic diseases · 2023
- 2Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
The Lancet. Rheumatology · 2024
📚 56 citations🎯 RCR 13.68Top 2% NIH🔓 Open Access - 3Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
Rheumatology (Oxford, England) · 2022
📚 43 citations🎯 RCR 4.34Top 10% NIHLire l'abstract Crossref ↓
AbstractObjectiveTo assess how RA and DMARDs affect gut permeability.MethodsTo explore colonic mucosa integrity, tight junction proteins zonula occludens-1, occludin and claudin 2 were quantified by immunohistochemistry on colonic biopsies in 20 RA patients and 20 age- and sex-matched controls. Staining intensity was assessed by two blinded independent readers. To explore intestinal permeability, serum concentrations of lipopolysaccharide binding protein (LBP), soluble CD14 (sCD14) and zonulin-related proteins (ZRPs) were evaluated by ELISA in another cohort of 59 RA patients: 21 patients naive for DMARDs [17 before and after introduction of a conventional synthetic DMARD (csDMARD)], 38 patients with severe RA [before and after introduction of a biological DMARD (bDMARD)] and 33 healthy controls.ResultsZ0-1 protein was less expressed in the colon of RA patients than controls [mean score 1.6 (s.e.m. 0.56) vs 2.0 (0.43), P = 0.01], while no significant difference was detected for occludin and claudin-2. RA patients had higher serum LBP and sCD14 concentrations than controls. LBP and sCD14 levels were significantly correlated with the 28-joint DAS (r = 0.61, P = 0.005 and r = 0.57, P = 0.01, respectively) while ZRP did not. bDMARD responders had significantly reduced LBP and sCD14 concentrations, unlike bDMARD non-responders and patients treated with csDMARDs.ConclusionRA patients have altered colonic tight junction proteins and increased serum biomarkers of intestinal permeability. There was a correlation between serological markers of intestinal permeability and disease activity as well as bDMARD response. These results suggest a link between impaired gut integrity and systemic inflammation in RA.
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal21
▼
Transversal21
▼- Accuracy of VIDAS(Ⓡ) TB-IGRA in TB patients and individuals with different thresholds of exposure
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026 · Journal Article
Goletti D, Banaei N, Batra R, Berger AE, et al.
📚 1 cit. - Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
RMD open · 2025 · Journal Article
Beretta M, Martin E, Fogel O, López-Medina C, et al.
- Phenotypes and prognosis of systemic sclerosis: A cluster analysis
Respiratory medicine and research · 2025 · Journal Article
Nowak S, Jaffuel D, Morel J, Ahmed E, et al.
🩺 Clinique - Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
La Revue de medecine interne · 2025 · Journal Article
de Boysson H, Devauchelle-Pensec V, Agard C, André M, et al.
📚 2 cit.🩺 Clinique - French protocol for the diagnosis and management of giant cell arteritis
La Revue de medecine interne · 2025 · Journal Article
de Boysson H, Devauchelle-Pensec V, Agard C, André M, et al.
📚 12 cit.🎯 RCR 4.97🔬→🩺 Translationnel - Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
Clinical and experimental rheumatology · 2024 · Journal Article
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, et al.
- Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study
RMD open · 2024 · Journal Article
Immediato Daien C, Georgescu V, Decarriere G, Mercier G, et al.
📚 2 cit. - Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants
BMC infectious diseases · 2024 · Journal Article
Chalouni M, Loubet P, Lhomme E, Ninove L, et al.
📚 2 cit.🩺 Clinique - Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
Joint bone spine · 2024 · Journal Article
Wendling D, Al Tabaa O, Chevet B, Fakih O, et al.
📚 12 cit.🎯 RCR 3.28🩺 Clinique - Infection prevention and vaccination in the rheumatic diseases
Joint bone spine · 2023 · Journal Article
Morel J
📚 3 cit.🔬→🩺 Translationnel - 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Annals of the rheumatic diseases · 2023 · Systematic Review
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, et al.
📚 151 cit.🎯 RCR 26.35🔬→🩺 Translationnel - One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023 · Observational Study
Loubet P, Wittkop L, Ninove L, Chalouni M, et al.
📚 19 cit.🎯 RCR 1.79🩺 Clinique - Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
Rheumatology (Oxford, England) · 2022 · Journal Article
Audo R, Sanchez P, Rivière B, Mielle J, et al.
📚 9 cit. - Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
Rheumatology (Oxford, England) · 2022 · Journal Article
Audo R, Sanchez P, Rivière B, Mielle J, et al.
📚 43 cit.🎯 RCR 4.34🔬→🩺 Translationnel - Évaluation systématique de la réponse humorale contre le SARS-CoV-2 dans une cohorte française de 283 patients atteints d’un rhumatisme inflammatoire chronique
Revue du rhumatisme (Ed. francaise : 1993) · 2022 · Journal Article
Gros C, Mariaggi AA, Meritet JF, André E, et al.
- CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis
Rheumatology (Oxford, England) · 2022 · Journal Article
Rempenault C, Mielle J, Schreiber K, Corbeau P, et al.
📚 15 cit.🎯 RCR 1.46 - Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases
Joint bone spine · 2022 · Journal Article
Gros C, Mariaggi AA, Meritet JF, André E, et al.
📚 1 cit.🔬→🩺 Translationnel - Glutamine promotes the generation of B10(+) cells via the mTOR/GSK3 pathway
European journal of immunology · 2022 · Journal Article
Mielle J, Morel J, Elhmioui J, Combe B, et al.
📚 10 cit. - Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study
Rheumatology (Oxford, England) · 2021 · Clinical Trial, Phase IV
Aouad K, Gaudin P, Vittecoq O, Morel J, et al.
📚 5 cit.🩺 Clinique - A French cohort for assessing COVID-19 vaccine responses in specific populations
Nature medicine · 2021 · Letter
Loubet P, Wittkop L, Tartour E, Parfait B, et al.
📚 18 cit.🔬→🩺 Translationnel - In-capillary (electrophoretic) digestion-reduction-separation: A smart tool for middle-up analysis of mAb
Journal of chromatography. A · 2021 · Journal Article
Dadouch M, Ladner Y, Bich C, Montels J, et al.
📚 7 cit.
Sjögren13
▼
Sjögren13
▼- Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Nguyen Y, Beydon M, Gottenberg JE, Morel J, et al.
📚 12 cit.🎯 RCR 4.86 - Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
Rheumatology (Oxford, England) · 2025 · Journal Article
Tison A, Jousse-Joulin S, Consigny M, Moog P, et al.
- Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
The Lancet. Rheumatology · 2024 · Journal Article
Nguyen Y, Nocturne G, Henry J, Ng WF, et al.
📚 56 cit.🎯 RCR 13.68🔬→🩺 Translationnel - Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren's syndrome
Cancer immunology, immunotherapy : CII · 2023 · Journal Article
Witkowski Durand Viel P, Henry K, Morel J, Jacot W, et al.
📚 5 cit. - French national diagnostic and care protocol for Sjögren's disease
La Revue de medecine interne · 2023 · Journal Article
Devauchelle-Pensec V, Mariette X, Benyoussef AA, Boisrame S, et al.
📚 11 cit.🎯 RCR 1.98🔬→🩺 Translationnel - [Infections in primary Sjögren's syndrome patients: "Real-life" study of 109 patients from Montpellier university hospital]
La Revue de medecine interne · 2022 · English Abstract
Henry K, Deligny C, Witkowski Durand Viel P, Morel J, et al.
- Hospitalizations for infections in primary Sjögren's syndrome patients: a nationwide incidence study
Annals of medicine · 2022 · Journal Article
Goulabchand R, Makinson A, Morel J, Witkowski-Durand-Viel P, et al.
📚 8 cit. - Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review
Autoimmunity reviews · 2022 · Journal Article
Coustal C, Guillope B, Serrand C, Morel J, et al.
📚 12 cit.🎯 RCR 1.42🔬→🩺 Translationnel - Hospitalization Risks for Neurological Disorders in Primary Sjögren's Syndrome Patients
Journal of clinical medicine · 2022 · Journal Article
Goulabchand R, Gabelle A, Ayrignac X, Malafaye N, et al.
📚 4 cit. - Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database
Autoimmunity reviews · 2021 · Journal Article
Goulabchand R, Malafaye N, Jacot W, Witkowski Durand Viel P, et al.
📚 29 cit.🎯 RCR 2.25 - Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium
Clinical and experimental rheumatology · 2021 · Journal Article
Retamozo S, Acar-Denizli N, Horváth IF, Ng WF, et al.
📚 27 cit.🎯 RCR 2.44 - Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion
Clinical and experimental rheumatology · 2021 · Journal Article
Dubost JJ, Couderc M, Pereira B, Mariette X, et al.
📚 8 cit. - Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren's Syndrome: Data from the French Health Insurance Database
Journal of clinical medicine · 2021 · Journal Article
Goulabchand R, Roubille C, Montani D, Fesler P, et al.
📚 12 cit.🎯 RCR 1.05
Biothérapies non-anti-TNF6
▼
Biothérapies non-anti-TNF6
▼- Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
Joint bone spine · 2025 · Journal Article
Morel J, Wetzman A, Wendling D, Soubrier M, et al.
📚 1 cit. - Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
BMJ open · 2025 · Clinical Trial Protocol
Pascart T, Fautrel B, Gottenberg JE, Ducoulombier V, et al.
🩺 Clinique - Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, et al.
📚 2 cit. - Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · Randomized Controlled Trial
Kedra J, Dieudé P, Giboin C, Marotte H, et al.
📚 3 cit.🩺 Clinique - Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease
RMD open · 2024 · Observational Study
Rempenault C, Lukas C, Tardivon L, Daien CI, et al.
🩺 Clinique - Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
Rheumatology (Oxford, England) · 2022 · Comparative Study
Rempenault C, Lukas C, Combe B, Herrero A, et al.
📚 28 cit.🎯 RCR 2.70
Anti-TNF2
▼
Anti-TNF2
▼- Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology (Oxford, England) · 2025 · Journal Article
Nguyen Y, Baron G, Hamamouche N, Belkhir R, et al.
📚 1 cit.🩺 Clinique - Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
Joint bone spine · 2022 · Letter
Ruyssen-Witrand A, Boudali Y, Pane I, Cantagrel A, et al.
📚 2 cit.
Rhumatisme psoriasique2
▼
Rhumatisme psoriasique2
▼- Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study
RMD open · 2024 · Journal Article
Kristensen LE, Ng KJ, Ngantcha M, Morel J, et al.
📚 4 cit.🎯 RCR 1.07🩺 Clinique - Toward a holistic management of skin and joint disorders in PsA patients
Rheumatology (Oxford, England) · 2022 · Editorial
Du-Thanh A, Girard C, Morel J, Roubille C
Corticothérapie1
▼
Corticothérapie1
▼- Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
csDMARDs1
▼
csDMARDs1
▼- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet. Rheumatology · 2025 · Journal Article
Morel J, Dernis E, Roux C, Richez C, et al.
📚 2 cit.🩺 Clinique
Échographie1
▼
Échographie1
▼- Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study
RMD open · 2024 · Journal Article
Mouterde G, Lukas C, Filippi N, Marin G, et al.
📚 4 cit.🎯 RCR 1.56
Épidémiologie & registres1
▼
Épidémiologie & registres1
▼- Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study
ACR open rheumatology · 2025 · Journal Article
Benamar S, Lukas C, Daien C, Gaujoux-Viala C, et al.
📚 2 cit.🔬→🩺 Translationnel
Essai clinique1
▼
Essai clinique1
▼- Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
JAK inhibiteurs1
▼
JAK inhibiteurs1
▼- Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
ACR open rheumatology · 2025 · Journal Article
Wollenhaupt J, Morel J, Daien C, Ruyssen-Witrand A, et al.
📚 1 cit.
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study
ACR open rheumatology · 2025 · Journal Article
Benamar S, Lukas C, Daien C, Gaujoux-Viala C, et al.
📚 2 cit.🔬→🩺 Translationnel
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis
Arthritis care & research · 2023 · Meta-Analysis
Wetzman A, Lukas C, Gaujoux-Viala C, Mamtani R, et al.
📚 18 cit.🎯 RCR 2.71🔬→🩺 Translationnel
Revue générale1
▼
Revue générale1
▼- Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis
Arthritis care & research · 2023 · Meta-Analysis
Wetzman A, Lukas C, Gaujoux-Viala C, Mamtani R, et al.
📚 18 cit.🎯 RCR 2.71🔬→🩺 Translationnel
Vascularites1
▼
Vascularites1
▼- Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review
Autoimmunity reviews · 2022 · Journal Article
Coustal C, Guillope B, Serrand C, Morel J, et al.
📚 12 cit.🎯 RCR 1.42🔬→🩺 Translationnel
Datasets & protocoles partagés
Celecoxib reduces viability and proliferation of synovial fibroblasts extracted from patients with rheumatoid arthritis (RA)
Image2011figshare<b>Copyright information:</b>Taken from "Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts"Arthritis Research & Therapy 2007;9(6):R128-R128.Published online
Celecoxib does not induce caspase activation in rheumatoid arthritis fibroblast-like synoviocytes (RA FLSs)
Image2011figshare<b>Copyright information:</b>Taken from "Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts"Arthritis Research & Therapy 2007;9(6):R128-R128.Published online
Additional file 6: Figure S6. of The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
Image2017FigshareShowing association between age of onset and onset of symptoms within RA patients of the Leiden EAC. (a) Results of logistic regression analyses of age at RA onset in relation to the onset of symptoms. OR of 1.01 indicat
Experimental investigation into the effect of stress on dissolution and growth of very soluble brittle salts in aqueous solution
Dissertation2000Johannes Gutenberg-Universität Mainz
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).